1. Home
  2. Analysis
  3. Finasteride
  4. Taltz

Finasteride and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Finasteride (finasteride) and Taltz (ixekizumab). Common drug interactions include pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Finasteride and Taltz. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Finasteride?

Finasteride has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 44,177 Finasteride users. Check the latest studies of Finasteride.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.

On Jul, 12, 2026

11 people who take Finasteride and Taltz together, and have interactions are studied.

Finasteride and Taltz drug interactions.

What are the common drug interactions of Finasteride and Taltz, by gender? *:

female:

n/a

male:

  1. Pneumonia
  2. Acute respiratory distress syndrome
  3. Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
  4. Nausea (feeling of having an urge to vomit)
  5. Polyp
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. T-cell lymphoma (a blood cell cancer)
  8. Dementia (madness)
  9. Dyspnoea (difficult or laboured respiration)
  10. Psoriasis (immune-mediated disease that affects the skin)

What are the common drug interactions of Finasteride and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Acute respiratory distress syndrome
  2. Dementia (madness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Pneumonia
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Respiratory tract inflammation
  7. Balance disorder
  8. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  9. Nausea (feeling of having an urge to vomit)
  10. T-cell lymphoma (a blood cell cancer)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 11 people, 100.00%
  2. Type 2 Diabetes: 1 person, 9.09%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
  4. High Blood Pressure: 1 person, 9.09%
  5. Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Finasteride and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Finasteride and Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Finasteride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Finasteride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taltz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on finasteride and ixekizumab (the active ingredients of Finasteride and Taltz, respectively), and Finasteride and Taltz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.